<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

In Vitro Drug
Screening Services for Discovery Programs

Whatever your project needs, we have the in vitro biology platform to support faster, better decision-making for your oncology drug discovery program. With extensive experience working with companies to support the in vitro pharmacology characterization of lead compounds, we’re committed to saving you precious time and resources by providing efficient screening platforms and validated 2D and 3D models, giving you confidence in your data.

2D Cell Lines and Panels-1
2D Cell Lines and Panels
Utilize the XenoBase®, the world’s largest commercial database of well-characterized cell lines to choose the correct cell lines for in vitro evaluation of your novel molecules.
Syngeneic Cells Lines
Syngeneic Cells Lines
Discover mouse tumor cells engineered to express humanized targets, such as PD-L1, to evaluate the efficacy of human-specific agents targeting humanized proteins expressed on tumor cells.
CRISPR_Cas9
CRISPR/Cas9
Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.
Organoids
Organoids
Incorporate the most translatable 3D in vitro models available into your oncology drug development programs with our exclusive Hubrecht Organoid Technology (HUB) license.
In Vitro High-Content Imaging
In Vitro High-Content Imaging
Leverage 2D and 3D bioluminescence and fluorescence optical imaging to enable in-life visualization of tumor growth and disease progression.

Reach Out to Us

If you would like additional information about any of our products or services, or to talk to one of our staff about your project and how we might be able to help, please call us or use the form. We welcome the opportunity to discuss your requirements, answer your questions, and provide you with the information you need.